skip to primary navigationskip to content
 

Vice Chancellor's Impact Award to Prof Nick Morrell

last modified Aug 03, 2017 12:26 PM

Prof Nick Morrell was among the winners of this year's Vice-Chancellor's Impact Awards that were announced at the prize ceremony on 13 July.

Severe high blood pressure in the lungs, known as idiopathic pulmonary arterial hypertension (PAH), is a rare disease that affects approximately 1,000 people in the UK. PAH usually affects young women and the average life expectancy is 3-5 years. Existing treatments improve symptoms but have little impact on survival.

Prof Morrell has introduced routine genetic testing for PAH, and has found that 1-in-4 patients carry a particular genetic mutation associated with more severe disease and worse survival rate. His research has identified new ways to treat the disease, the most promising of which is being commercialised through a university spin-out biotech company.

The Vice-Chancellor’s Impact Awards were established to recognise and reward those whose research has led to excellent impact beyond academia, whether on the economy, society, culture, public policy or services, health, the environment or quality of life. Each winner receives a prize of £1,000 and a trophy. More information about the awards and this year's winners can be found here.

Cambridge Cardiovascular logo - transparent

Logo design by Dr Ana-Mishel Spiroski and Dr Sarah Morgan.

 

We connect cardiovascular researchers in Cambridge.

Please follow us on Twitter for local news about research, events, funding calls, and open positions.

For inquiries about our research or the website, please contact Dr Katja Kivinen.